Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN.DL)

CAPS Rating: No stars

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

Recs

0
Player Avatar stockshakers93 (< 20) Submitted: 6/30/2012 9:14:01 AM : Outperform Start Price: $14.40 AMLN.DL Score: +108.72

Take over target if I needed access to one of the best line-ups of futures hits in the product pipeline world I would aquire AMLN.

Featured Broker Partners


Advertisement